Genmab A/S Current Tax Expense Income
Genmab A/S (GMAB) reported Current Tax Expense Income of $256.00 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-17.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:CurrentTaxExpenseIncome · last filed 2026-02-17
DKK
| Period end | Current Tax Expense Income 12 month | Current Tax Expense Income 12 month as first filed |
|---|---|---|
| 2024-12-31 | 1.80B DKK 6-K · filed 2025-02-12 | |
| 2023-12-31 | 1.30B DKK 6-K · filed 2025-02-12 | |
| 2022-12-31 | 1.48B DKK 6-K · filed 2025-02-12 | 1.50B DKK 6-K · filed 2023-02-22 |
| 2021-12-31 | 954.00M DKK 6-K · filed 2024-02-14 | 968.00M DKK 6-K · filed 2022-02-16 |
| 2020-12-31 | 1.19B DKK 6-K · filed 2023-02-22 | |
| 2019-12-31 | 444.00M DKK 6-K · filed 2022-02-16 | |
| 2018-12-31 | 161.00M DKK 6-K · filed 2021-02-23 | |
| 2017-12-31 | 133.00M DKK 20-F · filed 2020-03-30 |
USD
| Period end | Current Tax Expense Income 12 month |
|---|---|
| 2025-12-31 | $256.00M 20-F · filed 2026-02-17 |
| 2024-12-31 | $261.00M 20-F · filed 2026-02-17 |
| 2023-12-31 | $189.00M 20-F · filed 2026-02-17 |